Ian Purdy - Intuitive Surgical Senior Assurance
| ISRG Stock | USD 536.69 0.38 0.07% |
Executive
Ian Purdy is Senior Assurance of Intuitive Surgical
| Address | 1020 Kifer Road, Sunnyvale, CA, United States, 94086-5304 |
| Phone | 408 523 2100 |
| Web | https://www.intuitive.com |
Intuitive Surgical Management Efficiency
The company has return on total asset (ROA) of 0.0795 % which means that it generated a profit of $0.0795 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1597 %, meaning that it created $0.1597 on every $100 dollars invested by stockholders. Intuitive Surgical's management efficiency ratios could be used to measure how well Intuitive Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The Intuitive Surgical's current Return On Tangible Assets is estimated to increase to 0.13. The Intuitive Surgical's current Return On Capital Employed is estimated to increase to 0.13. At this time, Intuitive Surgical's Other Current Assets are most likely to increase significantly in the upcoming years. The Intuitive Surgical's current Total Current Assets is estimated to increase to about 8.3 B, while Net Tangible Assets are projected to decrease to roughly 5.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Alastair Robertson | ResMed Inc | N/A | |
| Erik Anderson | Hologic | 42 | |
| Ryan Simon | Hologic | N/A | |
| Howard Cyr | Teleflex Incorporated | N/A | |
| Diana SPHR | Hologic | N/A | |
| Ami Simunovich | Becton Dickinson and | N/A | |
| Jon Snodgres | Repligen | 58 | |
| Carlos MD | ResMed Inc | 58 | |
| Gulsen MBA | Bionano Genomics | 51 | |
| Greg Rodetis | Becton Dickinson and | N/A | |
| Jonathan JD | Bionano Genomics | 49 | |
| Heather Knight | Baxter International | 52 | |
| David Pendarvis | ResMed Inc | 65 | |
| Peter Dunne | Hologic | 68 | |
| Christian Voigtlander | ICU Medical | 56 | |
| Michael Garrison | Becton Dickinson and | 54 | |
| Guy Judkowski | Stereotaxis | N/A | |
| Konrad Dabrowski | Innovative Eyewear | 41 | |
| Sarah Comstock | Merit Medical Systems | N/A | |
| Jason Garland | Repligen | 50 | |
| Ekene Ofodile | Innovative Eyewear | N/A | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0795 |
Intuitive Surgical Leadership Team
Elected by the shareholders, the Intuitive Surgical's board of directors comprises two types of representatives: Intuitive Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intuitive. The board's role is to monitor Intuitive Surgical's management team and ensure that shareholders' interests are well served. Intuitive Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intuitive Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Rosa, Chief Commercial Officer and Executive VP | ||
| Mark Brosius, Senior Officer | ||
| Ian Purdy, Senior Assurance | ||
| Julian Nikolchev, Sr Strategy | ||
| Gillian EdD, Senior ServicesWorldwide | ||
| Jamie Samath, Principal Accounting Officer, VP and Corporate Controller | ||
| Gary JD, General VP | ||
| Gary Loeb, G Officer | ||
| Robert DeSantis, Executive Officer | ||
| Brian King, Treasurer VP | ||
| Gary Guthart, CEO and President and Director | ||
| Marc Bland, GM VP | ||
| Philip Kim, Head Relations | ||
| MD FACS, Executive Officer | ||
| Glenn Vavoso, Senior APAC | ||
| Brian Miller, Executive Officer | ||
| Patricia Wadors, Chief Officer | ||
| Henry Charlton, Senior Officer | ||
| Fredrik Widman, Principal VP | ||
| Marshall Mohr, Executive Services | ||
| Christopher Carlson, Corporate Research |
Intuitive Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intuitive Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0795 | ||||
| Profit Margin | 0.29 % | ||||
| Operating Margin | 0.28 % | ||||
| Current Valuation | 187.02 B | ||||
| Shares Outstanding | 356.18 M | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 90.26 % | ||||
| Number Of Shares Shorted | 3.85 M | ||||
| Price To Earning | 69.96 X |
Currently Active Assets on Macroaxis
When determining whether Intuitive Surgical is a strong investment it is important to analyze Intuitive Surgical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Intuitive Surgical's future performance. For an informed investment choice regarding Intuitive Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intuitive Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Intuitive Stock please use our How to Invest in Intuitive Surgical guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intuitive Surgical. If investors know Intuitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intuitive Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.345 | Earnings Share 6.23 | Revenue Per Share 22.22 | Quarterly Revenue Growth 0.169 | Return On Assets 0.0795 |
The market value of Intuitive Surgical is measured differently than its book value, which is the value of Intuitive that is recorded on the company's balance sheet. Investors also form their own opinion of Intuitive Surgical's value that differs from its market value or its book value, called intrinsic value, which is Intuitive Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intuitive Surgical's market value can be influenced by many factors that don't directly affect Intuitive Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intuitive Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intuitive Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intuitive Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.